Novel mutations and polymorphisms in the Fanconi anemia group C gene
Rachel A. Gibson(GlaxoSmithKline (United Kingdom)), Christopher G. Mathew(National Health Laboratory Service), Pushpa Vasudevan(Institute of Child Health), I. C. Pearson(Guy's Hospital), Farkondeh Birjandi(Guy's Hospital), Charmaine Havenga(University of the Free State), Ian Kesterton(Guy's Hospital), Thomas C. Pearson(Emory Healthcare), Atieh Hajianpour(Boston Children's Hospital), Laura H. Goldstein(Boston Medical Center), Irene Roberts(Hammersmith Hospital), Sarah E. Ball(St George's, University of London), Richard J. Cohn(UNSW Sydney), Sheila Mohan(Institute of Child Health), Thomy de Ravel(KU Leuven), R D Milner(King Faisal Specialist Hospital & Research Centre), M. Murer‐Orlando(Guy's Hospital), Inderjeet Dokal(Queen Mary University of London), Nicola Foot(Guy's Hospital), Isabel Marques(University of the Witwatersrand), Elena Samochatova(Ministry of Health of the Russian Federation), Judith Marsh(King's College London), Neil V. Morgan(University of Birmingham), S Jansen(University of the Free State), Juan Clinton Llerena(Fundação Oswaldo Cruz)
Cited by 45
Related Papers
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|Nature Genetics|2010|2.6k
Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease
|Nature Genetics|2017|1.5k
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
|Nature|1996|1.5k